ReviewVascular health and risk management2010

Pioglitazone and alogliptin combination therapy in type 2 diabetes: a pathophysiologically sound treatment.

Curtis Triplitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.